Clinical Trial Update: ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis. [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating ILUMYA in combination with HALOG Ointment 0.1% for plaque psoriasis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• HALOG Ointment 0.1%
• Ilumya (tildrakizumab)

Snippet

Sponsor: Psoriasis Treatment Center of Central New Jersey | Conditions: Psoriasis | Phase 4 | Status: RECRUITING